ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $358,560,451 | -4.4% | 2,932,048 | -0.7% | 0.04% | -2.7% |
Q2 2023 | $374,902,060 | -0.7% | 2,952,913 | +1.0% | 0.04% | -7.5% |
Q1 2023 | $377,509,908 | -7.6% | 2,922,806 | -6.0% | 0.04% | -13.0% |
Q4 2022 | $408,410,074 | -5.8% | 3,110,746 | -16.1% | 0.05% | -22.0% |
Q3 2022 | $433,780,000 | +19.2% | 3,708,802 | +19.9% | 0.06% | +25.5% |
Q2 2022 | $363,976,000 | -9.2% | 3,094,250 | +0.6% | 0.05% | -13.0% |
Q1 2022 | $400,752,000 | -30.9% | 3,075,611 | -19.1% | 0.05% | -25.0% |
Q4 2021 | $579,932,000 | +7.5% | 3,799,845 | +13.9% | 0.07% | -1.4% |
Q3 2021 | $539,304,000 | -2.2% | 3,335,623 | -1.0% | 0.07% | 0.0% |
Q2 2021 | $551,511,000 | -39.6% | 3,370,064 | -44.4% | 0.07% | -45.5% |
Q1 2021 | $913,355,000 | -26.2% | 6,066,383 | -25.8% | 0.13% | -29.8% |
Q4 2020 | $1,238,085,000 | +29.3% | 8,172,712 | +15.6% | 0.19% | +3.2% |
Q3 2020 | $957,621,000 | +33.5% | 7,072,018 | +34.7% | 0.18% | +16.4% |
Q2 2020 | $717,397,000 | +18.9% | 5,248,350 | -6.2% | 0.16% | -3.0% |
Q1 2020 | $603,112,000 | -5.0% | 5,597,848 | +6.2% | 0.16% | +10.8% |
Q4 2019 | $635,118,000 | +79.9% | 5,270,251 | +48.5% | 0.15% | +59.1% |
Q3 2019 | $353,106,000 | -9.8% | 3,548,805 | -1.0% | 0.09% | -10.6% |
Q2 2019 | $391,268,000 | -16.5% | 3,586,329 | -14.5% | 0.10% | -21.8% |
Q1 2019 | $468,765,000 | +15.6% | 4,192,887 | -0.3% | 0.13% | +9.9% |
Q4 2018 | $405,569,000 | -17.4% | 4,205,834 | +4.5% | 0.12% | -1.6% |
Q3 2018 | $490,944,000 | +15.1% | 4,026,110 | +3.7% | 0.12% | +7.0% |
Q2 2018 | $426,421,000 | +1.6% | 3,882,901 | -1.2% | 0.12% | -0.9% |
Q1 2018 | $419,509,000 | +6.1% | 3,930,195 | +6.1% | 0.12% | +7.4% |
Q4 2017 | $395,538,000 | -32.8% | 3,704,585 | +110.1% | 0.11% | -38.6% |
Q3 2017 | $588,228,000 | -8.7% | 1,763,328 | -15.1% | 0.18% | -9.7% |
Q2 2017 | $643,950,000 | -38.1% | 2,076,720 | -41.5% | 0.20% | +21.9% |
Q1 2017 | $1,040,816,000 | +28.5% | 3,549,010 | +16.3% | 0.16% | +21.2% |
Q4 2016 | $809,724,000 | +106.3% | 3,051,182 | +125.1% | 0.13% | -1.5% |
Q3 2016 | $392,414,000 | +74.9% | 1,355,678 | +55.5% | 0.13% | +65.4% |
Q2 2016 | $224,394,000 | -39.5% | 871,975 | -38.7% | 0.08% | -43.4% |
Q1 2016 | $371,172,000 | -40.3% | 1,423,146 | -22.5% | 0.14% | -36.4% |
Q4 2015 | $621,640,000 | -21.4% | 1,837,378 | -29.5% | 0.22% | -22.9% |
Q3 2015 | $790,520,000 | +15.8% | 2,606,139 | +40.9% | 0.29% | +23.2% |
Q2 2015 | $682,566,000 | -2.2% | 1,849,920 | -9.0% | 0.24% | -7.8% |
Q1 2015 | $698,139,000 | +29.2% | 2,032,837 | +14.1% | 0.26% | +29.8% |
Q4 2014 | $540,229,000 | -15.7% | 1,780,880 | -24.0% | 0.20% | -19.5% |
Q3 2014 | $640,854,000 | +11.8% | 2,342,044 | +5.0% | 0.25% | +9.3% |
Q2 2014 | $573,376,000 | +24.4% | 2,230,775 | +14.4% | 0.22% | +16.6% |
Q1 2014 | $460,800,000 | +91.3% | 1,949,238 | +83.8% | 0.19% | +89.2% |
Q4 2013 | $240,859,000 | +7.4% | 1,060,771 | -0.9% | 0.10% | -3.8% |
Q3 2013 | $224,303,000 | -16.3% | 1,070,145 | -30.5% | 0.11% | -21.5% |
Q2 2013 | $267,909,000 | – | 1,540,766 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |